Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma. (scientific article published on 14 February 2018)

Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population.

Q53540097

Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management

Q57579648

Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Q61053530

Non-Hodgkin lymphoma

Q84629067

The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma

Q84734074

Surveillance Imaging in Patients in Remission From Hodgkin and Diffuse Large B-Cell Lymphoma

Q89214247

Computed Tomography — An Increasing Source of Radiation Exposure

Q22121933

Report of the Committee on Hodgkin's Disease Staging Classification

Q28250452

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Q28251216

Projected cancer risks from computed tomographic scans performed in the United States in 2007

Q28267626

Solid cancer incidence in atomic bomb survivors: 1958-1998

Q29620810

Surveillance computed tomography scans for patients with lymphoma: is the risk worth the benefits?

Q34131221

The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin's lymphoma

Q34190099

Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors

Q34231093

Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas

Q34283822

Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries

Q34311769

The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question.

Q34389863

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

Q34402503

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

Q34663865

Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function

Q35056263

Radiation dose from medical imaging: a primer for emergency physicians

Q36153743

Positron emission tomographic scans in lymphoma: convention and controversy

Q36399538

Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy

Q37149757

Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.

Q38184954

Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know

Q38395116

Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma

Q38706816

Radiation-related cancer risks at low doses among atomic bomb survivors

Q39543993

Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study

Q41260547

Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission

Q44989353

Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma.

Q45996935

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

Q47607400

P275

Creative Commons Attribution 4.0 International

Q20007257

P6216

copyrighted